JBS NV JBS posts 117 Q4 2025 revenue growth shares fall 177 despite narrow EPS beat What SCHMID SHMDW is doing that smarter investors notice BMS BMY Future Plans BristolMyers Squibb posts 119 percent EPS beat on strong drug sales IPEXU Inflection holds off on disclosing quarterly financial metrics while laying out 2024 expansion targets FTDR Frontdoor shares jump 1327 as investors reward better than expected first quarter 2026 earnings results How ANI Pharma ANIP management quality drives results Bearish Sentiment 20260508 Gemini Surges After Winklevoss Capital Fund Injects 100 Million CEO Cites Undervaluation NPR Restructures Newsroom with Buyouts Confronts PostPublic Funding Future The Premium Tinned Tomato How Mutti Is Redefining a Pantry Staple MFS Investment Grade Municipal Trust CXH Advances 105 as Yield Appeal Supports Price Recovery QXO Launches Hostile Takeover Bid for Beacon Building Products TIC Solutions Inc TIC Q1 2026 Earnings Wide EPS Miss as Losses Deepen QTREX Secures 10 Million in Private Placement Funding